Sema Arayici
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Sema Arayici has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
- Hakan Ongun
Department of Pediatrics, Division of Neonatology, Faculty of Medicine, Akdeniz University (Antalya , Turkey)
6 shared publications - Kiymet Celik
Department of Pediatrics, Division of Neonatology, Faculty of Medicine, Akdeniz University (Antalya , Turkey)
6 shared publications Nurdan Uras
University of Health Sciences
4 shared publications- Zeynep Kihtir
Department of Pediatrics, Division of Neonatology, Antalya City Hospital (Antalya , Turkey)
4 shared publications - Fuat Emre Canpolat
Department of Neonatology, NICU, University of Health Sciences, Ankara Bilkent City Hospital, Bilkent/Çankaya, Ankara, Turkey
3 shared publications Gulsum Kadioglu Simsek
Ankara City Hospital
3 shared publications
Latest Publications
- Open Access
- 28 September 2026
- Published by Ankara Bilkent City Hospital in Turkish Journal of Pediatric Disease
- p. 1-7
Relationship between carboxyhemoglobin levels and indirect hyperbilirubinemia in preterm newborns
Objective: Neonatal jaundice, caused by elevated bilirubin levels, may lead to severe neurological complications, particularly in preterm infants. The aim of this study was to evaluate the predictive value of early carboxyhemoglobin (COHb) levels for identifying indirect hyperbilirubinemia and the need for phototherapy in preterm neonates. Materials and Methods: This retrospective study included 297 preterm infants admitted to the neonatal intensive care unit (NICU). COHb, bilirubin, and related laboratory parameters were evaluated at 0–6 hours, 24 hours, and 48–96 hours after birth. Statistical analyses included the Mann–Whitney U test, Spearman correlation analysis, receiver operating characteristic (ROC) curve analysis, and logistic regression. Results: Among 297 preterm newborns, 151 (50.8%) required phototherapy. Early COHb levels showed only very weak correlations with subsequent bilirubin concentrations. COHb levels at 0–6 hours and 24 hours demonstrated poor discriminatory performance for phototherapy requirement, with AUC values of 0.560 and 0.583, respectively. Neither measurement was independently associated with phototherapy requirement in multivariable analyses, whereas birth weight <2000 g remained an independent determinant in both models. Conclusion: Although early COHb levels showed weak correlations with indirect bilirubin levels in preterm neonates, they were not reliable independent predictors of phototherapy requirement. These findings suggest that COHb has limited clinical utility as a standalone biomarker for guiding treatment decisions.
- 28 September 2026
- Published by Ankara Bilkent City Hospital in Turkish Journal of Pediatric Disease
- p. 1-7
Open AccessRelationship between carboxyhemoglobin levels and indirect hyperbilirubinemia in preterm newborns
Objective: Neonatal jaundice, caused by elevated bilirubin levels, may lead to severe neurological complications, particularly in preterm infants. The aim of this study was to evaluate the predictive value of early carboxyhemoglobin (COHb) levels for identifying indirect hyperbilirubinemia and the need for phototherapy in preterm neonates. Materials and Methods: This retrospective study included 297 preterm infants admitted to the neonatal intensive care unit (NICU). COHb, bilirubin, and related laboratory parameters were evaluated at 0–6 hours, 24 hours, and 48–96 hours after birth. Statistical analyses included the Mann–Whitney U test, Spearman correlation analysis, receiver operating characteristic (ROC) curve analysis, and logistic regression. Results: Among 297 preterm newborns, 151 (50.8%) required phototherapy. Early COHb levels showed only very weak correlations with subsequent bilirubin concentrations. COHb levels at 0–6 hours and 24 hours demonstrated poor discriminatory performance for phototherapy requirement, with AUC values of 0.560 and 0.583, respectively. Neither measurement was independently associated with phototherapy requirement in multivariable analyses, whereas birth weight <2000 g remained an independent determinant in both models. Conclusion: Although early COHb levels showed weak correlations with indirect bilirubin levels in preterm neonates, they were not reliable independent predictors of phototherapy requirement. These findings suggest that COHb has limited clinical utility as a standalone biomarker for guiding treatment decisions.
- 11 February 2026
- Published by SAGE Publications in Journal of Neonatal-Perinatal Medicine
- Vol. 19 (5) , 542-546
Lamellar body count in gastric aspirates of healthy term newborns: A prospective evaluation
Background: Lamellar body count serves as a crucial indicator of pulmonary surfactant production, with deficiencies implicated in various pulmonary conditions causing respiratory distress in term infants. This study aimed to assess lamellar body count in gastric aspirates of healthy term newborns using an automated hematology analyzer. Methods: A prospective study was conducted, obtaining gastric aspirates from healthy infants within 30 min of birth, with dithiothreitol utilized as a liquefying agent. Lamellar body count analysis was conducted using the platelet channel of the cell counter. Results: A total of 262 gastric aspirate samples were analyzed. The median lamellar body count was found to be 441,000/μL (49,000–3,493,000). Gestational age–specific lamellar body count values were described using percentile distributions. Conclusion: This pioneering study presents the first evaluation of lamellar body count in gastric aspirates of healthy term newborns. The findings suggest that lamellar body count measurement in gastric aspirates may provide supportive information on pulmonary surfactant status in term newborns and offer baseline physiological data in healthy term infants, serving as a foundation for future studies evaluating its potential role in the management of respiratory disorders.
- 11 February 2026
- Published by SAGE Publications in Journal of Neonatal-Perinatal Medicine
- Vol. 19 (5) , 542-546
Lamellar body count in gastric aspirates of healthy term newborns: A prospective evaluation
Background: Lamellar body count serves as a crucial indicator of pulmonary surfactant production, with deficiencies implicated in various pulmonary conditions causing respiratory distress in term infants. This study aimed to assess lamellar body count in gastric aspirates of healthy term newborns using an automated hematology analyzer. Methods: A prospective study was conducted, obtaining gastric aspirates from healthy infants within 30 min of birth, with dithiothreitol utilized as a liquefying agent. Lamellar body count analysis was conducted using the platelet channel of the cell counter. Results: A total of 262 gastric aspirate samples were analyzed. The median lamellar body count was found to be 441,000/μL (49,000–3,493,000). Gestational age–specific lamellar body count values were described using percentile distributions. Conclusion: This pioneering study presents the first evaluation of lamellar body count in gastric aspirates of healthy term newborns. The findings suggest that lamellar body count measurement in gastric aspirates may provide supportive information on pulmonary surfactant status in term newborns and offer baseline physiological data in healthy term infants, serving as a foundation for future studies evaluating its potential role in the management of respiratory disorders.
- 11 February 2026
- Published by SAGE Publications in Journal of Neonatal-Perinatal Medicine
- Vol. 19 (5) , 500-507
Assessing blood carboxyhemoglobin levels as an early predictor of phototherapy in ABO incompatible newborns
Background: This study aimed to evaluate blood carboxyhemoglobin (COHb) levels as an indicator of hemolysis and as an early predictor of phototherapy requirement in newborns with blood type A or B born to mothers with blood type O. Methods: In this prospective observational study, enrolled infants were divided into two groups: Group 1 comprised newborns with maternal blood type O and infant blood type A or B, while Group 2 consisted of newborns born to mothers without blood type O. Total serum bilirubin and carboxyhemoglobin levels were assessed from cord blood samples at birth and venous blood samples at 24 h of life and compared between groups. None of the infants required intravenous immunoglobulin therapy or blood transfusion. Results: A total of 100 term infants were included. Mean carboxyhemoglobin levels in cord blood and at 24 h of life were significantly higher in Group 1 compared with Group 2 (0.55 vs 0.48, p = 0.04; 0.69 vs 0.36, p = 0.002, respectively). The onset of phototherapy occurred significantly earlier in Group 1 than in Group 2 (48 vs 90 h, p = 0.01). Conclusion: Elevated carboxyhemoglobin levels were observed in newborns with ABO incompatibility, and higher levels were associated with an earlier requirement for phototherapy.
- 11 February 2026
- Published by SAGE Publications in Journal of Neonatal-Perinatal Medicine
- Vol. 19 (5) , 500-507
Assessing blood carboxyhemoglobin levels as an early predictor of phototherapy in ABO incompatible newborns
Background: This study aimed to evaluate blood carboxyhemoglobin (COHb) levels as an indicator of hemolysis and as an early predictor of phototherapy requirement in newborns with blood type A or B born to mothers with blood type O. Methods: In this prospective observational study, enrolled infants were divided into two groups: Group 1 comprised newborns with maternal blood type O and infant blood type A or B, while Group 2 consisted of newborns born to mothers without blood type O. Total serum bilirubin and carboxyhemoglobin levels were assessed from cord blood samples at birth and venous blood samples at 24 h of life and compared between groups. None of the infants required intravenous immunoglobulin therapy or blood transfusion. Results: A total of 100 term infants were included. Mean carboxyhemoglobin levels in cord blood and at 24 h of life were significantly higher in Group 1 compared with Group 2 (0.55 vs 0.48, p = 0.04; 0.69 vs 0.36, p = 0.002, respectively). The onset of phototherapy occurred significantly earlier in Group 1 than in Group 2 (48 vs 90 h, p = 0.01). Conclusion: Elevated carboxyhemoglobin levels were observed in newborns with ABO incompatibility, and higher levels were associated with an earlier requirement for phototherapy.
- Open Access
- 29 June 2025
- Published by SAGE Publications in Journal of Human Lactation
- Vol. 41 (3) , 371-378
Relationship Between Birthweight for Gestational Age and Colostrum Macronutrient Composition: A Comparative Analysis in Small, Appropriate, and Large for Gestational Age Infants
Background: Human milk and colostrum have been well studied; however, limited data are available on the variations in macronutrient content when compared across different infant weight categories for infants with similar gestational ages. Research Aims: To compare the colostrum macronutrient content of participants who delivered term infants classified as small for gestational age, appropriate for gestational age, and large for gestational age. Methods: In this exploratory cross-sectional observational study ( N = 252), colostrum (on postpartum Day 2) was collected and categorized by gestational weight group. The protein, fat, carbohydrate, and energy levels of colostrum were measured using a mid-infrared human milk analyzer. Values were dichotomized at the median and compared using logistic regression. Results: Median colostrum protein content was significantly higher in the small for gestational age (4.8 [IQR = 3–6.4] gr/dl) and large for gestational age (4.4 [IQR = 3.5–5.3] g/dl) groups compared to the appropriate for gestational age group (2.8 [IQR = 2.1–3.7] g/dl; p < 0.001). Median carbohydrate content was significantly higher in the large for gestational age group (5.3 [IQR = 4.2–6] g/dl) than appropriate for gestational age group (4.5 [IQR = 3.5–5.3] g/dl; p = 0.002). In multivariate analysis, being SGA or LGA was independently associated with higher milk protein content ( OR 4.68; 95% CI [2.25, 9.77; p < 0.001; and OR 6.76; 95% CI [3.30, 13.87]; p < 0.001, respectively). Only being LGA was associated with higher carbohydrate content ( OR 2.74; 95% CI [1.46, 5.16]; p = 0.002). Conclusion: Colostrum macronutrient content varies depending on whether the birthweight is small or large for gestational age. Studies are needed to investigate these potential associations and the clinical consequences of this relationship.
- 29 June 2025
- Published by SAGE Publications in Journal of Human Lactation
- Vol. 41 (3) , 371-378
Open AccessRelationship Between Birthweight for Gestational Age and Colostrum Macronutrient Composition: A Comparative Analysis in Small, Appropriate, and Large for Gestational Age Infants
Background: Human milk and colostrum have been well studied; however, limited data are available on the variations in macronutrient content when compared across different infant weight categories for infants with similar gestational ages. Research Aims: To compare the colostrum macronutrient content of participants who delivered term infants classified as small for gestational age, appropriate for gestational age, and large for gestational age. Methods: In this exploratory cross-sectional observational study ( N = 252), colostrum (on postpartum Day 2) was collected and categorized by gestational weight group. The protein, fat, carbohydrate, and energy levels of colostrum were measured using a mid-infrared human milk analyzer. Values were dichotomized at the median and compared using logistic regression. Results: Median colostrum protein content was significantly higher in the small for gestational age (4.8 [IQR = 3–6.4] gr/dl) and large for gestational age (4.4 [IQR = 3.5–5.3] g/dl) groups compared to the appropriate for gestational age group (2.8 [IQR = 2.1–3.7] g/dl; p < 0.001). Median carbohydrate content was significantly higher in the large for gestational age group (5.3 [IQR = 4.2–6] g/dl) than appropriate for gestational age group (4.5 [IQR = 3.5–5.3] g/dl; p = 0.002). In multivariate analysis, being SGA or LGA was independently associated with higher milk protein content ( OR 4.68; 95% CI [2.25, 9.77; p < 0.001; and OR 6.76; 95% CI [3.30, 13.87]; p < 0.001, respectively). Only being LGA was associated with higher carbohydrate content ( OR 2.74; 95% CI [1.46, 5.16]; p = 0.002). Conclusion: Colostrum macronutrient content varies depending on whether the birthweight is small or large for gestational age. Studies are needed to investigate these potential associations and the clinical consequences of this relationship.
- 6 May 2025
- Published by Georg Thieme Verlag KG in Klinische Padiatrie
Nasal CPAP and BiPAP as the Initial Respiratory Support in Preterm Infants: A Randomized Controlled Trial
This study aimed to compare the nasal continuous positive airway pressure (nCPAP) and bi-level positive airway pressure (BiPAP) in preterm infants with respiratory distress syndrome (RDS).Preterm infants (≤32 weeks of gestation) were randomly assigned, at birth, into two study groups: nCPAP or BiPAP. Primary outcomes (surfactant administration and failure of non-invasive respiratory support within the first 72 hours), and secondary outcomes (duration of ventilation support, pneumothorax, bronchopulmonary dysplasia, patent ductus arteriosus, necrotizing enterocolitis, intraventricular haemorrhage, retinopathy of prematurity, time to total enteral feeding, length of hospital stay, and mortality) were assessed.A total of 188 preterm infants with RDS were analysed. Mean gestational age was 28.8±1.8 weeks (nCPAP) versus 29±1.9 weeks (BiPAP). There were no statistically significant differences between groups in the failure of non-invasive respiratory support (25% vs. 33%, RR: 0.74, 95% CI: 0.47–1.17) or surfactant administration (35% vs. 38%, RR: 0.92, 95% CI: 0.49–1.71). No significant differences were observed in secondary outcomes between the two groups. Subgroup analysis of infants<30 weeks yielded similar results.Although two-level CPAP theoretically offers benefits, BiPAP was not superior to nCPAP as initial support in preterm infants with RDS. This underscores the continued value of the simpler, well-established nCPAP and the need for multicentre trials involving preterm infants of varying gestational ages.
- 6 May 2025
- Published by Georg Thieme Verlag KG in Klinische Padiatrie
Nasal CPAP and BiPAP as the Initial Respiratory Support in Preterm Infants: A Randomized Controlled Trial
This study aimed to compare the nasal continuous positive airway pressure (nCPAP) and bi-level positive airway pressure (BiPAP) in preterm infants with respiratory distress syndrome (RDS).Preterm infants (≤32 weeks of gestation) were randomly assigned, at birth, into two study groups: nCPAP or BiPAP. Primary outcomes (surfactant administration and failure of non-invasive respiratory support within the first 72 hours), and secondary outcomes (duration of ventilation support, pneumothorax, bronchopulmonary dysplasia, patent ductus arteriosus, necrotizing enterocolitis, intraventricular haemorrhage, retinopathy of prematurity, time to total enteral feeding, length of hospital stay, and mortality) were assessed.A total of 188 preterm infants with RDS were analysed. Mean gestational age was 28.8±1.8 weeks (nCPAP) versus 29±1.9 weeks (BiPAP). There were no statistically significant differences between groups in the failure of non-invasive respiratory support (25% vs. 33%, RR: 0.74, 95% CI: 0.47–1.17) or surfactant administration (35% vs. 38%, RR: 0.92, 95% CI: 0.49–1.71). No significant differences were observed in secondary outcomes between the two groups. Subgroup analysis of infants<30 weeks yielded similar results.Although two-level CPAP theoretically offers benefits, BiPAP was not superior to nCPAP as initial support in preterm infants with RDS. This underscores the continued value of the simpler, well-established nCPAP and the need for multicentre trials involving preterm infants of varying gestational ages.
- Open Access
- 23 April 2025
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 61 (7) , 1138-1144
Non‐Syndromic Congenital Sodium Diarrhoea With a SLC9A3 Gene Variant: A Case Report
- 23 April 2025
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 61 (7) , 1138-1144
Open AccessNon‐Syndromic Congenital Sodium Diarrhoea With a SLC9A3 Gene Variant: A Case Report
- 3 February 2025
- Published by Wiley in Pediatric Pulmonology
- Vol. 60 (2) , e27512
Nasal Intermittent Positive Pressure Ventilation During Neonatal Endotracheal Intubation: A Randomized Controlled Trial
Background: This prospective, multicenter, randomized controlled trial aimed to determine whether the use of nasal intermittent positive pressure ventilation (NIPPV) during neonatal endotracheal intubation increased the rate of successful intubation without physiological instability during all intubation attempts. Material and Methods: In total, 150 infants were randomly assigned to either an NIPPV or standard care group ( n = 75 each). The primary outcome was successful intubation without physiological instability (defined as ≥ 20% decline in the peripheral oxygen saturation [SpO 2 ] from preintubation value or bradycardia with a heart rate < 100 beats/min) during all intubation attempts. Results: The mean postmenstrual age of the infants was 32.5 weeks, with a median weight of 1552 g at the time of intubation. The incidence of successful intubation without physiological instability during all intubation attempts was significantly higher in the NIPPV group (64%) than that in the standard care group (42.7%) ( p = 0.009). This difference was particularly significant when inexperienced practitioners were involved. In the NIPPV group, the rates of bradycardia (18.7% vs. 41.3%) and severe desaturation (30.7% vs. 49.3%) were significantly lower, whereas the lowest SpO 2 (85% vs. 76%) and lowest heart rate (118 vs. 105 beats/min) were significantly higher. Conclusion: NIPPV during endotracheal intubation increased the incidence of successful intubation without physiological instability during intubation attempts in neonates while reducing the rate of hypoxia and bradycardia.
- 3 February 2025
- Published by Wiley in Pediatric Pulmonology
- Vol. 60 (2) , e27512
Nasal Intermittent Positive Pressure Ventilation During Neonatal Endotracheal Intubation: A Randomized Controlled Trial
Background: This prospective, multicenter, randomized controlled trial aimed to determine whether the use of nasal intermittent positive pressure ventilation (NIPPV) during neonatal endotracheal intubation increased the rate of successful intubation without physiological instability during all intubation attempts. Material and Methods: In total, 150 infants were randomly assigned to either an NIPPV or standard care group ( n = 75 each). The primary outcome was successful intubation without physiological instability (defined as ≥ 20% decline in the peripheral oxygen saturation [SpO 2 ] from preintubation value or bradycardia with a heart rate < 100 beats/min) during all intubation attempts. Results: The mean postmenstrual age of the infants was 32.5 weeks, with a median weight of 1552 g at the time of intubation. The incidence of successful intubation without physiological instability during all intubation attempts was significantly higher in the NIPPV group (64%) than that in the standard care group (42.7%) ( p = 0.009). This difference was particularly significant when inexperienced practitioners were involved. In the NIPPV group, the rates of bradycardia (18.7% vs. 41.3%) and severe desaturation (30.7% vs. 49.3%) were significantly lower, whereas the lowest SpO 2 (85% vs. 76%) and lowest heart rate (118 vs. 105 beats/min) were significantly higher. Conclusion: NIPPV during endotracheal intubation increased the incidence of successful intubation without physiological instability during intubation attempts in neonates while reducing the rate of hypoxia and bradycardia.
- Open Access
- 12 September 2024
- Published by Wiley
Nasal intermittent positive pressure ventilation (NIPPV) during neonatal endotracheal intubation: A randomized controlled trial
Background: The present study aimed to determine whether the use of nasal intermittent positive pressure ventilation (NIPPV) during neonatal endotracheal intubation increases the rate of successful intubation without physiological instability during all intubation attempts. Material and Methods: The present study was designed as a prospective, multicenter, randomized, controlled study conducted with neonates undergoing endotracheal intubation. The infants were assigned randomly to either the NIPPV group or the standard care group. The primary outcome was successful intubation without physiological instability (defined as ≥20% decline in the peripheral oxygen saturation [SpO 2 ] from pre-intubation value or bradycardia with a heart rate of Results: A total of 150 infants were enrolled (75 for the NIPPV group and 75 for the standart-care group). The infants had a mean postmenstrual age of 32.5 weeks and a median weight of 1552 g at the time of intubation. The incidence of successful intubation without physiological instability during all intubation attempts was significantly higher in the NIPPV group (64%) compared to the standard-care group (42.7%) (p = 0.009). This difference was particularly significant when inexperienced practitioners were involved. In the NIPPV group, the rate of bradycardia and severe desaturation was significantly lower, while the lowest SpO 2 level and the lowest heart rate level were significanlty higher. Conclusion: NIPPV during endotracheal intubation increases the incidence of successful intubation without physiological instability during all intubation attempts in neonates, while reducing the rate of hypoxia and bradycardia.
- 12 September 2024
- Published by Wiley
Open AccessNasal intermittent positive pressure ventilation (NIPPV) during neonatal endotracheal intubation: A randomized controlled trial
Background: The present study aimed to determine whether the use of nasal intermittent positive pressure ventilation (NIPPV) during neonatal endotracheal intubation increases the rate of successful intubation without physiological instability during all intubation attempts. Material and Methods: The present study was designed as a prospective, multicenter, randomized, controlled study conducted with neonates undergoing endotracheal intubation. The infants were assigned randomly to either the NIPPV group or the standard care group. The primary outcome was successful intubation without physiological instability (defined as ≥20% decline in the peripheral oxygen saturation [SpO 2 ] from pre-intubation value or bradycardia with a heart rate of Results: A total of 150 infants were enrolled (75 for the NIPPV group and 75 for the standart-care group). The infants had a mean postmenstrual age of 32.5 weeks and a median weight of 1552 g at the time of intubation. The incidence of successful intubation without physiological instability during all intubation attempts was significantly higher in the NIPPV group (64%) compared to the standard-care group (42.7%) (p = 0.009). This difference was particularly significant when inexperienced practitioners were involved. In the NIPPV group, the rate of bradycardia and severe desaturation was significantly lower, while the lowest SpO 2 level and the lowest heart rate level were significanlty higher. Conclusion: NIPPV during endotracheal intubation increases the incidence of successful intubation without physiological instability during all intubation attempts in neonates, while reducing the rate of hypoxia and bradycardia.
- 28 February 2024
- Published by Hacettepe University Institute of Child Health in The Turkish Journal of Pediatrics
- Vol. 66 (1) , 17-24
Early neonatal outcomes in infants of mothers with organ transplantation under immunosuppressive treatment
Background. This study aimed to examine early clinical and laboratory findings in infants born to mothers who had organ transplants and received immunosuppressive treatment. Methods. Between 2016 and 2023, the study examined infants of mothers who underwent organ transplantation and were receiving immunosuppressive treatment, and followed at the Department of Neonatology at Akdeniz University. Demographic, clinical, and laboratory characteristics of mothers and infants were recorded. On the first day of life, complete blood count values were examined, as well as potassium levels on the first, third, and seventh days, and creatinine levels on the third and seventh days. The tacrolimus blood level was calculated by taking the average of the tacrolimus blood values of the mother measured during the pregnancy. The infants were evaluated for any potential morbidities caused by intrauterine immunosuppressive drug exposure. Results. The study included 21 mothers (some with multiple pregnancies) and 27 infants. According to the findings of this study, 74% of these infants were born premature, 67% had low birth weight, and all were delivered via cesarean section. Prematurity was associated with the morbidities found in the infants. In the early period, lymphopenia was detected in 37%, neutropenia in 25.9%, thrombocytopenia in 11.1%, hyperkalemia in 18.5%, and creatinine elevation in 7.4%, all of which returned to normal within a few days. There was no significant relationship between maternal tacrolimus blood levels and infant potassium and creatinine levels. Conclusion. Apart from an increased risk of prematurity, low birth weight, and cesarean delivery, no effects were observed in these infants during the early period. However, long-term follow-up is necessary to monitor for any potential morbidities.
- 28 February 2024
- Published by Hacettepe University Institute of Child Health in The Turkish Journal of Pediatrics
- Vol. 66 (1) , 17-24
Early neonatal outcomes in infants of mothers with organ transplantation under immunosuppressive treatment
Background. This study aimed to examine early clinical and laboratory findings in infants born to mothers who had organ transplants and received immunosuppressive treatment. Methods. Between 2016 and 2023, the study examined infants of mothers who underwent organ transplantation and were receiving immunosuppressive treatment, and followed at the Department of Neonatology at Akdeniz University. Demographic, clinical, and laboratory characteristics of mothers and infants were recorded. On the first day of life, complete blood count values were examined, as well as potassium levels on the first, third, and seventh days, and creatinine levels on the third and seventh days. The tacrolimus blood level was calculated by taking the average of the tacrolimus blood values of the mother measured during the pregnancy. The infants were evaluated for any potential morbidities caused by intrauterine immunosuppressive drug exposure. Results. The study included 21 mothers (some with multiple pregnancies) and 27 infants. According to the findings of this study, 74% of these infants were born premature, 67% had low birth weight, and all were delivered via cesarean section. Prematurity was associated with the morbidities found in the infants. In the early period, lymphopenia was detected in 37%, neutropenia in 25.9%, thrombocytopenia in 11.1%, hyperkalemia in 18.5%, and creatinine elevation in 7.4%, all of which returned to normal within a few days. There was no significant relationship between maternal tacrolimus blood levels and infant potassium and creatinine levels. Conclusion. Apart from an increased risk of prematurity, low birth weight, and cesarean delivery, no effects were observed in these infants during the early period. However, long-term follow-up is necessary to monitor for any potential morbidities.
- 2 February 2024
- Published by Georg Thieme Verlag KG in Journal of Pediatric Infectious Diseases
- Vol. 19 (03) , 127-139
Challenges in Diagnosis and Treatment of Neonatal Ventriculitis: A Case Report and Systematic Review of Difficult-to-Treat Central Nervous System Infection Resistant to Conventional Therapy
Objective Ventriculitis is an example of the increasing global trend in difficult-to-treat infections in neonates caused by pathogens resistant to conventional therapies. This article describes the first use of intravenous and intraventricular tigecycline to treat ventriculitis caused by vancomycin-resistant enterococci in a preterm neonate and systematically review the literature on challenges posed by the definitions, diagnosis, and treatment of neonatal ventriculitis Methods The authors searched PubMed and Internet search engines for “ventriculitis” in the period from 2003 to 2023 restricting the research to “Newborn,” “Human,” “English language,” and “full-text availability.” Results Thirty-seven publications (20 case reports, 6 case series, and 11 research articles) were extracted upon research. Preterm birth, posthemorrhagic ventricular dilatation requiring placement of ventricular access devices, and sepsis preceded neonatal ventriculitis. Infections caused by rare microorganisms, in particular gram-negative bacteria resistant to conventional therapies, predominated in the publications describing the need for a combination of intravenous (IV) and intraventricular (IVT) therapies. Survivors of neonatal ventriculitis developed neurodevelopmental impairments such as hydrocephalus, seizures, motor function, hearing, and vision impairment. Conclusion Clinical suspicion of ventriculitis indicated by subtle signs is key for prompt diagnosis. Effective IV and IVT antibiotics are essential to prevent serious sequelae and mortality. The drug delivery method should be changed if there is no clinical response. This study emphasizes the urgent need for pediatric trials of antibiotics against organisms resistant to other drugs.
- 2 February 2024
- Published by Georg Thieme Verlag KG in Journal of Pediatric Infectious Diseases
- Vol. 19 (03) , 127-139
Challenges in Diagnosis and Treatment of Neonatal Ventriculitis: A Case Report and Systematic Review of Difficult-to-Treat Central Nervous System Infection Resistant to Conventional Therapy
Objective Ventriculitis is an example of the increasing global trend in difficult-to-treat infections in neonates caused by pathogens resistant to conventional therapies. This article describes the first use of intravenous and intraventricular tigecycline to treat ventriculitis caused by vancomycin-resistant enterococci in a preterm neonate and systematically review the literature on challenges posed by the definitions, diagnosis, and treatment of neonatal ventriculitis Methods The authors searched PubMed and Internet search engines for “ventriculitis” in the period from 2003 to 2023 restricting the research to “Newborn,” “Human,” “English language,” and “full-text availability.” Results Thirty-seven publications (20 case reports, 6 case series, and 11 research articles) were extracted upon research. Preterm birth, posthemorrhagic ventricular dilatation requiring placement of ventricular access devices, and sepsis preceded neonatal ventriculitis. Infections caused by rare microorganisms, in particular gram-negative bacteria resistant to conventional therapies, predominated in the publications describing the need for a combination of intravenous (IV) and intraventricular (IVT) therapies. Survivors of neonatal ventriculitis developed neurodevelopmental impairments such as hydrocephalus, seizures, motor function, hearing, and vision impairment. Conclusion Clinical suspicion of ventriculitis indicated by subtle signs is key for prompt diagnosis. Effective IV and IVT antibiotics are essential to prevent serious sequelae and mortality. The drug delivery method should be changed if there is no clinical response. This study emphasizes the urgent need for pediatric trials of antibiotics against organisms resistant to other drugs.